Abstract: | Spero Health is opening a new OBOT (office‐based outpatient treatment) center for patients with opioid use disorder (OUD) in Savannah, Tennessee, in response to the high demand for treatment in the COVID‐19 pandemic. This clinic will utilize telehealth and in‐person visit options. Spero Health has more than 35 clinics thro‐ughout Kentucky, Ohio, Indiana and Tennessee, treating more than 7,000 patients a month. Spero Health accepts TennCare, the state's Medicaid plan, and most commercial insurance plans. |